|
|
Volumn 3, Issue 5, 2012, Pages 516-517
|
|
Voltage-dependent K+ channels as oncotargets in malignant gliomas
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM);
CHLORIDE CHANNEL BLOCKING AGENT;
CITALOPRAM;
DIGOXIN;
IMIPRAMINE;
LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;
POTASSIUM CHANNEL;
POTASSIUM CHANNEL KV10.1;
TEMOZOLOMIDE;
TM 601;
UNCLASSIFIED DRUG;
VOLTAGE GATED POTASSIUM CHANNEL;
ANTIDEPRESSANT AGENT;
CALCIUM SIGNALING;
CANCER CHEMOTHERAPY;
CANCER GRADING;
CANCER INVASION;
CANCER PROGNOSIS;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL EFFECTIVENESS;
CONCENTRATION RESPONSE;
DEPRESSION;
DRUG ADMINISTRATION ROUTE;
DRUG EFFICACY;
GLIOBLASTOMA;
GLIOMA;
HEART FAILURE;
HUMAN;
NOTE;
PROSTATE CANCER;
PROTEIN TARGETING;
ANIMAL;
APOPTOSIS;
BRAIN TUMOR;
CELL MOTION;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG RESISTANCE;
EDITORIAL;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
PATHOLOGY;
ANIMALS;
ANTIDEPRESSIVE AGENTS;
APOPTOSIS;
BRAIN NEOPLASMS;
CELL MOVEMENT;
CITALOPRAM;
DRUG RESISTANCE;
GLIOMA;
HUMANS;
IMIPRAMINE;
MOLECULAR TARGETED THERAPY;
POTASSIUM CHANNELS, VOLTAGE-GATED;
|
|
EID: 84867308136
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.514 Document Type: Note |
|
Times cited : (10)
|
|
References (9)
|
